Charlton, Michael R.
Alam, Altaf
Shukla, Akash
Dashtseren, Bekhbold
Lesmana, Cosmas Rinaldi Adithya
Duger, Davadoorj
Payawal, Diana Alcantara
Duy Cuong, Do
Jargalsaikhan, Ganbolor
Cua, Ian Homer Yee
Sollano, Jose Decena
Singh, Karam Romeo
Madan, Kaushal
Win, Khin Maung
Kyi, Khin Pyone
Tun, Kyaw Soe
Salih, Mohd.
Rastogi, Mukul
Saraf, Neeraj
Thuy, Pham Thi Thu
Hien, Pham Tran Dieu
Gani, Rino Alvani
Mohamed, Rosmawati
Tanwandee, Tawesak
Piratvisuth, Teerha
Sukeepaisarnjaroen, Wattana
Naing, Win
Hashmi, Zahid Yasin
Funding for this research was provided by:
Mylan Pharmaceuticals Ltd.
Article History
Received: 18 February 2020
Accepted: 25 May 2020
First Online: 14 July 2020
Compliance with ethical standards
:
: Author Michael Charlton: Consulting and research support for Gilead Sciences, Merck, AbbVie, Novartis and Only consulting support for Mylan. Author Teerha Piratvisuth received commercial research and funding from Gilead Sciences, Roche Diagnostic, Janssen, Fibrogen, VIR and received honoraria from Bristol-Meyers Squibb, Gilead Sciences, Bayer, Abbott, Esai, Mylan Ferring and MSD.